{
    "organizations": [],
    "uuid": "c027e6bb63ec46934c27810606d0950fd17673a2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cellnovo-says-insulin-cartridges-m/brief-cellnovo-says-insulin-cartridges-manufacturing-line-expected-to-be-fully-operational-by-q2-2018-idUSFWN1P30VK",
    "ord_in_thread": 0,
    "title": "BRIEF-Cellnovo Says Insulin Cartridges ‍Manufacturing Line Expected To Be Fully Operational By Q2 2018​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - CELLNOVO GROUP SA:\n* CELLNOVO PROVIDES AN UPDATE ON MANUFACTURING OF INSULIN CARTRIDGES\n* ‍OPTIMISATIONS ARE ON SCHEDULE FOR COMPLETION IN Q1 OF 2018​\n* - IN AUGUST FLEX AND CELLNOVO BEGAN OPTIMISATION PROCESS THAT IS PART OF PLANNING FOR LARGE-SCALE PRODUCTION\n* OPTIMISATIONS TO BE FOLLOWED BY REQUISITE CHECKS THAT COME BEFORE NEXT PHASE OF LARGE-SCALE PRODUCTION​\n* ‍MANUFACTURING LINE IS EXPECTED TO BE FULLY OPERATIONAL BY Q2 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-09T01:07:00.000+02:00",
    "crawled": "2018-01-09T17:12:26.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "cellnovo",
        "group",
        "sa",
        "cellnovo",
        "provides",
        "update",
        "manufacturing",
        "insulin",
        "cartridge",
        "schedule",
        "completion",
        "q1",
        "august",
        "flex",
        "cellnovo",
        "began",
        "optimisation",
        "process",
        "part",
        "planning",
        "production",
        "optimisation",
        "followed",
        "requisite",
        "check",
        "come",
        "next",
        "phase",
        "line",
        "expected",
        "fully",
        "operational",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}